HEPATITIS C VIRUS

HEPATITIS C VIRUS was reported 563 times

HEPATITIS C VIRUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 10 0.0004
1 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7 0.0001
2 Nucleoside Analog Antiviral [EPC] 8 0.0001
3 Sulfone [EPC] 1 0.0001
4 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 10 0.0001
5 Bile Acid [EPC] 2 0.0001
6 Protease Inhibitor [EPC] 2 0.0000
7 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
8 Phenothiazine [EPC] 1 0.0000
9 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
10 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
11 Purine Antimetabolite [EPC] 2 0.0000
12 Azole Antifungal [EPC] 3 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Nitroimidazole Antimicrobial [EPC] 1 0.0000
15 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
16 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
17 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
18 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
19 Opioid Agonist [EPC] 2 0.0000
20 Benzodiazepine [EPC] 5 0.0000
21 Leukocyte Growth Factor [EPC] 1 0.0000
22 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
23 Corticosteroid [EPC] 8 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
25 Estrogen [EPC] 1 0.0000
26 Thiazide Diuretic [EPC] 1 0.0000
27 beta-Adrenergic Blocker [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
29 Kinase Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 1 0.0000